← Back
$CRSP All transactions

CRISPR Therapeutics AG

M

$ Value

Shares

100,000

Price

Filed

Oct 20

Insider

Name

Kulkarni Samarth

Title

Chief Executive Officer

CIK

0001682019

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-16

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

305,096

Footnotes

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. | Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. | This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028.

Filing Info

Accession No.

0001193125-25-243819

Form Type

4

Issuer CIK

0001674416

Kulkarni Samarth's History

Date Ticker Type Value
2026-03-23 CRSP $469K
2026-03-20 CRSP M
2026-03-20 CRSP A $0
2026-03-20 CRSP A $0
2026-03-20 CRSP M
2025-10-17 CRSP $3.5M
2025-10-16 CRSP M
2025-10-16 CRSP M
2025-10-14 CRSP $283K
2025-10-13 CRSP M

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20